Product References
Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
PloS one
Vallecillo-Zúniga ML,Rathgeber MF,Poulson PD,Hayes S,Luddington JS,Gill HN,Teynor M,Kartchner BC,Valdoz J,Stowell C,Markham AR,Arthur C,Stowell S,Van Ry PM
PA5-47565 was used in Immunocytochemistry-immunoflourescence to reveal Gal-1 mediates disease pathologies through both changes in integral myogenic protein expression and mechanical membrane stabilization.
Tue Oct 27 00:00:00 UTC 2020
Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
PloS one
Vallecillo-Zúniga ML,Rathgeber MF,Poulson PD,Hayes S,Luddington JS,Gill HN,Teynor M,Kartchner BC,Valdoz J,Stowell C,Markham AR,Arthur C,Stowell S,Van Ry PM
PA5-47565 was used in Immunocytochemistry-immunoflourescence to reveal Gal-1 mediates disease pathologies through both changes in integral myogenic protein expression and mechanical membrane stabilization.
Tue Oct 27 00:00:00 UTC 2020
Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
PloS one
Vallecillo-Zúniga ML,Rathgeber MF,Poulson PD,Hayes S,Luddington JS,Gill HN,Teynor M,Kartchner BC,Valdoz J,Stowell C,Markham AR,Arthur C,Stowell S,Van Ry PM
PA5-47565 was used in Immunocytochemistry-immunoflourescence to reveal Gal-1 mediates disease pathologies through both changes in integral myogenic protein expression and mechanical membrane stabilization.
Tue Oct 27 00:00:00 UTC 2020